Form 4: Bessemer Venture Partners Sells Hinge Health Shares

Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.

Summary

• Director Elliott Robinson, representing Bessemer Venture Partners, reported the sale of Hinge Health (HNGE) Class A Common Stock.
• On June 1, 2026, a total of 100,000 shares were sold at a weighted average price of $61.08.
• On June 2, 2026, an additional 19,621 shares were sold at a weighted average price of $60.34.
• The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it is a routine disclosure of insider selling by a venture capital firm rather than a fundamental change in company operations.

Positives

• The transactions were executed at market prices ranging between $60.00 and $61.44, indicating liquidity for the stock.

Negatives

• Insider selling by a major venture capital firm can sometimes be perceived as a lack of long-term confidence or a move to realize gains.

Risks

• Continued divestment by major institutional shareholders could exert downward pressure on the stock price.

Future Outlook

No specific forward-looking guidance provided in this filing.

Management Comments

• The reporting person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest.

Industry Context

StockSavvy.ai notes that venture capital firms frequently divest portions of their holdings in portfolio companies following IPO lock-up expirations or as part of standard fund lifecycle management, which is common in the digital health sector.

Comparison to Industry Standards

• The sale of shares by venture capital firms post-listing is a standard industry practice for liquidity events.
• The pricing aligns with typical market volatility for growth-stage health technology companies.

Related Party Transactions

• The reporting person is a partner at Bessemer Venture Partners and has an indirect economic interest in the shares held by the Bessemer Funds.

Stakeholder Impact

• Shareholders may observe minor price fluctuations due to the volume of shares sold.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Hinge Health, HNGE, Insider Trading, Bessemer Venture Partners, Form 4, Equity Sale